Company intelligence / Profile preview

Angelus Partners

Maitland, Florida, United States

Ownership: Private
Development stage: Other

Overview

Angelus Partners is a private investment firm focused on healthcare-related investing rather than operating as a drug developer or therapeutic product company. Available public information indicates that it manages Angelus-branded funds and has participated in medical technology investments, including Signifier Medical Technologies. The firm appears to specialize in identifying disruptive opportunities across medical technology, services, infrastructure, diagnostics, and life science tools. It should be categorized as a healthcare-focused investor, not as a biotech, pharma, CRO, or product-based medtech company with an internal clinical pipeline.

Industry: Investors

Partnerships

Signifier Medical Technologies

Beyond the preview

Go deeper on Angelus Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angelus Partners.

Explore the full profile